Armas Pharmaceuticals reintroduces lidocaine jellyLidocaine jelly 2% is a topical anesthetic used in various medical applications, including urological and endoscopic procedures, to provide localized pain relief. Fresenius receives FDA nod for Prolia, Xgeva biosimilarsFresenius Kabi reached a global settlement with Amgen concerning their denosumab biosimilars, allowing launch in the United States in mid-2025 and in Europe later in 2025. Hikma launches cisatracurium besylate, gets OK for Kloxxado in Canada Cisatracurium besylate injection has a market value of approximately $14 million in the 12 months ending January 2025, per IQVIA. Dr Reddy's completes sale of its Louisiana subsidiary This sale includes its manufacturing facility in Shreveport, La. ANI Pharmaceuticals intros generic Alinia Generic Alinia is used to treat diarrhea caused by certain parasites. Glenmark receives FDA OK for generic Pataday OTC Generic Pataday OTC will be distributed in the United States by Glenmark Therapeutics, USA. Biocon Pharma gets FDA nod for norepinephrine bitartrate injection Norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with acute hypotension. FDA accepts BLA submission from Dr. Reddy's, Alvotech for proposed Prolia, Xgeva biosimilars After approval by the FDA, AVT03 is expected to be supplied in a single-dose prefilled syringe containing 60 mg in a 1 ml solution, as well as a 120 mg/1.7 ml solution in a single-dose vial. FDA gives Lupin tentative nod for generic Firdapse Amifampridine tablets are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 years of age and older. Avenacy intros 5 generics Avenacy is launching five injectable antibiotic products. First Previous 3 4 5 6 7 Next Last
